SweetValueLab
Write for us

Broadcom vs Marvell Technology AVGO vs MRVL

Broadcom and Marvell Technology on one sheet: valuation multiples, growth, margins, debt, dividends and returns, each section labelled with the period it covers, from the companies' filings. Add or remove a stock above the sheet; the link holds the set.

Compare other stocks
AVGOMRVL
Often compared:+ NVDA+ AMD+ QCOM

What differs most

generated from the numbers below
  • One-year price return: Marvell Technology +177.9%, Broadcom −7.0%.
  • Market value: Broadcom $1.57T, Marvell Technology $204.74B.
  • Operating margin: Broadcom 48.4%, Marvell Technology 16.8%.
  • Return on equity: Broadcom 38.4%, Marvell Technology 14.2%.

Price return

2025-10-26 → 2026-10-26
AVGO−7.0%
MRVL+177.9%
-100%0%100%200%300%2025-10-242026-04-272026-10-26
Prices at the close on 2026-10-26

Profile

latest
Sector
Technology
Technology
Industry
Semiconductors
Semiconductors
Market value
$1.57T
$204.74B
Enterprise value
$1.61T
$206.09B
Employees
33,000
7,480
Revenue per employee (TTM)
$2.7M
$1.3M

Our models

nightlythe valuation on each stock's page
Price vs model
34% undervalued vs model
410% overvalued vs model
Model range
$333–988
$30.42–78.87
Models in the headline
1
1
FCF growth priced in, at a 10% return
30.5%
49.2%
Every model, its assumptions and its range: AVGO valuation · MRVL valuation. The growth priced in, at any return: AVGO reverse DCF · MRVL reverse DCF.

Trading

close 2026-10-26
Last close
$329.17
$233.78
52-week high
$481.57
$316.43
52-week low
$293.41
$73.73
Price vs 52-week high
−31.6%
−26.1%
Price vs 52-week low
+12.2%
+217.1%
Average daily volume / shares
0.5%
3.1%
Beta
1.48
2.26

Returns

to 2026-10-26
1 month
−6.7%
−10.8%
3 months
−13.8%
+20.4%
6 months
−22.1%
+42.3%
Year to date
−4.9%
+175.1%
1 year
−7.0%
+177.9%
1 year, dividends added
−6.3%
+178.2%
2 years
+90.3%
+186.5%

Valuation

price × TTM to Aug 2026
P/E (TTM)
42.0×
77.4×
P/E on consensus EPS (next FY)
28.2×
55.5×
Price / sales
17.6×
21.7×
EV / sales
18.0×
21.8×
EV / EBITDA
30.5×
72.6×
Price / book
15.8×
11.0×
Price / free cash flow (FY)
58.4×
146.6×
Free-cash-flow yield (FY)
1.7%
0.7%

Growth

AVGO TTM and FY2025 · MRVL TTM and FY2026
Revenue growth (TTM)
—
—
Revenue growth, consensus next FY
+65.9%
+47.2%
Revenue, 3-year CAGR
24.4%
11.4%
Revenue, 5-year CAGR
21.7%
22.5%
EPS growth (TTM)
—
—
EPS growth, consensus next FY
+144.8%
+37.2%
EPS, 3-year CAGR
21.6%
—
Free cash flow, 3-year CAGR
18.2%
9.2%
Diluted shares, 3-year change
+14.7%
+2.1%

Profitability

TTM to Aug 2026
Gross margin (FY)†
67.8%
51.0%
Operating margin
48.4%
16.8%
EBITDA margin
59.1%
30.0%
Net margin
42.9%
27.9%
Free-cash-flow margin (FY)
42.1%
17.0%
Return on equity
38.4%
14.2%
Return on assets
20.3%
9.6%
Asset turnover
0.47
0.34
† Gross margin (FY): As filed. Companies draw the cost-of-revenue line in different places, so gross margins of two companies in one industry can differ for that reason alone; operating margin does not depend on where the line is drawn.

Balance sheet

MRQ Aug 2026
Cash
$23.98B
$3.93B
Total debt
$59.42B
$5.29B
Net debt
$35.44B
$1.35B
Debt / equity
0.6×
0.3×
Net debt / EBITDA (TTM)
0.7×
0.5×
Interest coverage (FY)
7.9×
6.6×
Current ratio (FY)
1.71
2.01

Dividends

trailing 12 months
Dividend yield
0.8%
0.1%
Dividends per share
$2.60
$0.24
Payout ratio (of TTM EPS)
33.2%
8.0%
Dividend per share, 5-year CAGR
12.5%
0.0%
Frequency
Quarterly
Quarterly

Ownership and activity

last 90 days · latest 13F
Tracked superinvestors holding (13F)
15
3
Insider open-market buys (Form 4)
$0
$0
Insider sales (Form 4)
$250.0M
$866K
Analyst upgrades
1
1
Analyst downgrades
0
0

Statements

AVGO income TTM to Aug 2026 · cash flow FY2025 · MRVL income TTM to Aug 2026 · cash flow FY2026
Revenue
$89.10B
$9.45B
EBITDA
$52.65B
$2.84B
Operating income
$43.09B
$1.58B
Net income
$38.27B
$2.64B
EPS (diluted)
$7.84
$3.02
Operating cash flow
$27.54B
$1.75B
Capital expenditure
−$623.0M
−$354.1M
Free cash flow
$26.91B
$1.40B
Dividends paid
$11.14B
$205.1M

Keep comparing

the matchups people search for

Statements, prices, dividends and consensus estimates from Financial Modeling Prep; insider trades from Form 4 and holdings from 13F. Refreshed nightly. A comparison of filed numbers, not a recommendation to buy, sell or hold any security.